Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Pershing Square’s Favorite Stock Picks

Bill Ackman’s Pershing Square made a lot of changes to its portfolio. Here is a summary of these changes:

Bill Ackman in front of Perishi

Ackman Ups the Ante on the FO Horse

By the looks of it, Ackman may be at it again. At end the third quarter, Ackman had roughly $6 billion in his Pershing Square portfolio. Of that, over 18% was devoted to Fortune Brands (FO). FO had been Ackman’s third largest position in the second quarter at just under $1.1 billion. Ackman’s FO position now tops his position in JCP, which was his largest in the second quarter at $1.34 billion.

Top Holdings in Ackman’s Pershing Square Portfolio

Ackman did not increase his position in JCP, nor in General Growth Properties (GGP), which was the second largest position in Ackman’s portfolio during the second quarter. At the end of the third quarter, it ranked third in his portfolio. KFT had ranked fifth in Ackman’s portfolio during the second quarter but, as of the end of September, it ranks fourth, after Ackman increased Pershing Square’s position in the company by 13.28%. Citigroup (C), which had been Ackman’s fourth largest position in the second quarter, slipped to the fifth largest position. Ackman did increase Pershing Square’s holding in the company during the third quarter, by 11% in fact. Citigroup had slipped in rankings because Ackman increased his other top holdings more.

(Read the rest of the article here)

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!